P & G | GenomeWeb

P & G

Navigenics has added a new medications feature to its service offerings and is providing customers with a wallet-sized report that contains a condensed version of the genetic response to as many as 12 prescription drugs, which the company began reporting as part of its DTC service this week.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.